8H5901 control CD 26
Active Purchase Order Awarded Last action
- Contract number
- N6817123P6017
- Awardee
-
Abbott Laboratories, SA UEI U1FJNN5XQM15 Part of Abbott Laboratories
- Awarding agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Obligated
- $128,097
Award facts
- Opportunity
-
- N6817123Q6004 Solicitation number
- Contract value 78% obligated
-
- $128,096.96 Current, with exercised options
- $164,082.79 Potential, with all options
- Completion date 75% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Spain
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $32,454 | |
| Exercise an Option | $32,644 | |
| Exercise an Option | $30,815 | |
| Supplemental Agreement for work within scope | -$3,667 | |
| Original award | $35,851 |
About this award
Abbott Laboratories, SA (Laboratorios Knoll S.A.), a subsidiary of Abbott Laboratories headquartered in North Chicago, Illinois, was awarded a firm fixed-price purchase order valued at $164,082.79 by the Defense Health Agency on January 26, 2023, for reagents to support Naval Hospital Rota in Spain. The contract, which carries no set-aside designation, has an ultimate completion date of January 28, 2028. Abbott Laboratories, SA operates as the Abbott Diagnostic Division and will perform all work at the Spain location. This procurement aligns with the Defense Health Agency's broader mission to provide comprehensive diagnostic and medical support to Department of Defense healthcare facilities.
This award reflects Abbott's established position as a critical supplier of diagnostic reagents and laboratory consumables to federal healthcare institutions. Abbott Molecular Inc., a subsidiary of the parent company, maintains multiple Blanket Purchase Agreements and General Services Administration schedule contracts for in-vitro diagnostics and reagents across numerous Veterans Integrated Service Networks, enabling streamlined procurement of molecular diagnostic products. The Naval Hospital Rota contract represents a continuation of Abbott's long-term strategic partnership with the Department of Defense healthcare system, providing essential diagnostic reagents that support clinical laboratory operations and patient care capabilities at this overseas military medical facility.
Quick answers
Who was awarded contract N6817123P6017?
N6817123P6017 was awarded to Abbott Laboratories, SA by Naval Supply Systems Command (Department of the Navy) on January 26, 2023.
How much is contract N6817123P6017 worth?
The government has obligated $128,097 on N6817123P6017. Its potential value, with all options, is $164,083.
Which agency awarded contract N6817123P6017?
Naval Supply Systems Command (Department of the Navy) awarded N6817123P6017, with funding from Defense Health Agency (Department of Defense).
Was contract N6817123P6017 competed?
The extent of competition for N6817123P6017 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award